A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma
NCT01279967
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Malignant Pleural Mesothelioma
Interventions
DRUG:
ADI-PEG 20
Sponsor
Barts & The London NHS Trust
Collaborators
[object Object]
[object Object]